Literature DB >> 3035549

Regulation of the host range of human papovavirus JCV.

L Feigenbaum, K Khalili, E Major, G Khoury.   

Abstract

Human papovavirus JCV is associated with the human demyelinating disorder progressive multifocal leukoencephalopathy. In tissue culture, the virus is largely restricted to growth in primary human fetal glial cell. In this study, we demonstrate two levels of regulation of the viral host range. Expression of the early JCV mRNA, which encodes the essential viral protein, large tumor antigen (T antigen), depends on recognition of the early enhancer/promoter elements by tissue-specific factors found in both human and rodent glial cells. In the presence of JCV T antigen, viral DNA replication requires a species-specific factor, presumably a component of DNA polymerase, which is found in a wide range of primate cells. We further demonstrate that simian virus 40 T antigen has sufficient homology to efficiently substitute for the analogous JCV protein in initiating viral DNA replication.

Entities:  

Mesh:

Year:  1987        PMID: 3035549      PMCID: PMC304942          DOI: 10.1073/pnas.84.11.3695

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships.

Authors:  B L Padgett; C M Rogers; D L Walker
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

3.  JC Papovavirus in progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; A E Hodach; S M Chou
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

4.  Detection of polyoma virus DNA in PML-brain tissue by (in situ) hybridization.

Authors:  K Dörries; R T Johnson; V ter Meulen
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

5.  Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus).

Authors:  W T London; S A Houff; D L Madden; D A Fuccillo; M Gravell; W C Wallen; A E Palmer; J L Sever; B L Padgett; D L Walker; G M ZuRhein; T Ohashi
Journal:  Science       Date:  1978-09-29       Impact factor: 47.728

6.  Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus.

Authors:  O Narayan; J B Penney; R T Johnson; R M Herndon; L P Weiner
Journal:  N Engl J Med       Date:  1973-12-13       Impact factor: 91.245

7.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

8.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

9.  Species-specific in vitro synthesis of DNA containing the polyoma virus origin of replication.

Authors:  Y Murakami; T Eki; M Yamada; C Prives; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Human papovavirus (JC): induction of brain tumors in hamsters.

Authors:  D L Walker; B L Padgett; G M ZuRhein; A E Albert; R F Marsh
Journal:  Science       Date:  1973-08-17       Impact factor: 47.728

View more
  44 in total

Review 1.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region.

Authors:  P N Jensen; E O Major
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

2.  Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.

Authors:  P Ferrante; M Mediati; R Caldarelli-Stefano; L Losciale; R Mancuso; A E Cagni; R Maserati
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

3.  Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma.

Authors:  A Rencic; J Gordon; J Otte; M Curtis; A Kovatich; P Zoltick; K Khalili; D Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Analysis of JC virus DNA replication using a quantitative and high-throughput assay.

Authors:  Jong Shin; Paul J Phelan; Panharith Chhum; Nazym Bashkenova; Sung Yim; Robert Parker; David Gagnon; Ole Gjoerup; Jacques Archambault; Peter A Bullock
Journal:  Virology       Date:  2014-08-24       Impact factor: 3.616

5.  Enhancer/promoter activities of regulatory regions of representative JC virus isolates.

Authors:  J D Martin; P Li
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  Regulation of a human neurotropic virus promoter, JCVE: identification of a novel activator domain located upstream from the 98 bp enhancer promoter region.

Authors:  S Ahmed; M Chowdhury; K Khalili
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

7.  Requirements for species-specific papovavirus DNA replication.

Authors:  E R Bennett; M Naujokas; J A Hassell
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Direct isolation and characterization of JC virus from urine samples of renal and bone marrow transplant patients.

Authors:  C Myers; R J Frisque; R R Arthur
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Human fetal Schwann cells support JC virus multiplication.

Authors:  J G Assouline; E O Major
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

10.  Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha.

Authors:  C F Chang; G L Gallia; V Muralidharan; N N Chen; P Zoltick; E Johnson; K Khalili
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.